The broad, long-term objectives of our laboratory are to define unique regions of structure and function in viral RNAs, allowing them to be attacked without sustaining heavy cellular damage. There are millions of patients with chronic HCV infection in the United States and abroad, but the efficiency of present therapies is a difficult problem. HCV is thus a leading candidate for new antiviral therapies based on targeting unique RNA sequences, structures and functions of the virus. Since such treatments will work best in conserved sequences of the HCV genome, our project will focus on the 5' terminal domain of the viral RNA, which includes the Internal Ribosome Entry Site (IRES), the unusual structure with which HCV and several other RNA viruses signal protein synthesis initiation, in striking contrast to cellular mRNA molecules, which employ a conventional 7-methyl guanosine cap structure.
The specific aims of this proposal are: (i) To map the conserved 5' terminal 400 bases of the HCV genome for regions of conserved sequence, secondary structure, and local tertiary structural elements, emphasizing unique regions combining all three elements. Techniques we already use, including oligonucleotide binding, gel shift, RNase H-directed cleavage, RNase III digestion and RNA-RNA crosslinking by UV light will all be employed. (ii) We will employ ribosome binding and protein synthesis assays to identify the exact RNA domains needed for IRES function, and will test modified and mutant sequences to map their fine structure. Our direct ribosome binding site isolation method employing RNAase protection in the reticulocyte lysate will be employed to pinpoint these IRES sequences and their structures derived in aim (i). (iii) We will design ribozyme targeting sequences and other agents which will be directed against key functional domains characterized in aims (i) and (ii). Included will be design and testing of External Guide Sequences (EGSs) for human RNase P in liver cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK056424-02
Application #
6177909
Study Section
Special Emphasis Panel (ZDK1-GRB-5 (M1))
Program Officer
Doo, Edward
Project Start
1999-09-30
Project End
2004-08-31
Budget Start
2000-09-01
Budget End
2001-08-31
Support Year
2
Fiscal Year
2000
Total Cost
$307,106
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Birk, Alex V; Leno, Endri; Robertson, Hugh D et al. (2003) Interaction between ATP and catecholamines in stimulation of platelet aggregation. Am J Physiol Heart Circ Physiol 284:H619-25
Lyons, Alita J; Robertson, Hugh D (2003) Detection of tRNA-like structure through RNase P cleavage of viral internal ribosome entry site RNAs near the AUG start triplet. J Biol Chem 278:26844-50
Circle, David A; Lyons, Alita J; Neel, Olivia D et al. (2003) Recurring features of local tertiary structural elements in RNA molecules exemplified by hepatitis D virus RNA. RNA 9:280-6
Birk, Alex V; Bubman, Darya; Broekman, M Johan et al. (2002) Role of a novel soluble nucleotide phospho-hydrolase from sheep plasma in inhibition of platelet reactivity: hemostasis, thrombosis, and vascular biology. J Lab Clin Med 139:116-24
Birk, Alex V; Broekman, M Johan; Gladek, Eva M et al. (2002) Role of extracellular ATP metabolism in regulation of platelet reactivity. J Lab Clin Med 140:166-75
Lytle, J Robin; Wu, Lily; Robertson, Hugh D (2002) Domains on the hepatitis C virus internal ribosome entry site for 40s subunit binding. RNA 8:1045-55
Nadal, Anna; Martell, Maria; Lytle, J Robin et al. (2002) Specific cleavage of hepatitis C virus RNA genome by human RNase P. J Biol Chem 277:30606-13
Lyons, A J; Lytle, J R; Gomez, J et al. (2001) Hepatitis C virus internal ribosome entry site RNA contains a tertiary structural element in a functional domain of stem-loop II. Nucleic Acids Res 29:2535-41
Lytle, J R; Wu, L; Robertson, H D (2001) The ribosome binding site of hepatitis C virus mRNA. J Virol 75:7629-36